![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 18, 15400-15406, May 3, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, October 26, 2001, and in revised form, January 31, 2002
Ionizing radiation at clinical dose levels
activates both pro- and anti-proliferative signal transduction
pathways, the balance of which determines cell fate. The initiating and
amplifying mechanisms involved in the activation are poorly understood.
We demonstrate that one mechanism involves stimulation of constitutive
nitric-oxide synthase (NOS) activity. NOS activity of Chinese hamster
ovary cells was measured by the arginine Ionizing radiation activates several cytoplasmic signal
transduction pathways involving Tyr kinases, protein kinase C,
ERK-1/2,1 ceramide, and
Ca2+ homeostatic mechanisms (1-8). Because these pathways
represent both pro- and anti-proliferative signals, their relative
balance can determine cell fate (2). The underlying mechanisms by which cytoplasmic ionization events initiate these pathways are not known.
There are only a few primary ionization events ( In our studies cellular ROS was measured with dihydro-DCF at the single
cell level by fluorescence microscopy (15). ROS generation occurred
within seconds of radiation exposure (1-10 Gy) and persisted for 2-5
min post-radiation. The amount of ROS generated per responding cell was
relatively constant in this dose range. With increasing radiation dose
there was a corresponding increase in number of cells generating
elevated ROS, suggesting an all-or-nothing response. Genetic and
pharmacological analyses indicated that the radiation-induced ROS
resulted from the Ca2+-dependent propagation of
a reversible permeability transition from one mitochondrion
to another. A similar mechanism for enhanced ROS generation resulting
from a reversible permeability transition has been described for
cardiomyocytes (18).
RNS may also have a significant role in the response of cells to
radiation. NO reacts with O NO is formed during the NOS-catalyzed conversion of arginine to
citrulline. Three isoforms of NOS with similar catalytic mechanisms have been described (28). The NOS-1 and -3 isoforms are constitutively expressed in many cell types, and their activities are
Ca2+/calmodulin-dependent. NOS-1 and -3 produce
relatively low amounts of NO compared with inducible NOS-2. NOS-2
tightly binds calmodulin, and its activity is largely
Ca2+-independent. Here we demonstrate that low doses of
radiation transiently activate NOS-1. Previous conclusions about
radiation-induced ROS based on the use of DCF fluorescence measurements
must be modified to include RNS and RNS-dependent
downstream signaling.
Cells and Cell Culture--
The CHO-K1 cells were grown in RPMI
1640 plus 5% fetal bovine serum and antibiotics. Cells were
transfected with the LipofectAMINE PLUSTM kit (Invitrogen)
according to the manufacturer's directions.
Reagents--
Reagents and their suppliers are as follows:
fluorescent probes (Molecular Probes, Eugene, OR); anti-nitro-Tyr
antibodies (Upstate Biochemicals, Inc., Lake Placid, NY); anti-Mn-SOD
antibody (Oxis Biochemical, CA); anti-ERK1/2, anti-Myc, anti-SHP-1, and anti-SHP-2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA); secondary antibodies conjugated to alkaline phosphatase (Promega, Madison, WI); and [3H]arginine (ICN Biochemical).
Plasmids for rat brain wild type (pnNOS) or dominant negative NOS-1
mutants (pHeme-RedF and pHeme) have been described (29). Plasmids
encoding the Determination of NOS Activity of Intact Cells--
Subconfluent
CHO-K1 cells in 35-mm culture dishes were incubated for 20 min at
37 °C in 145 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM CaCl2,
10 mM Hepes (pH 7.4), 5 mM glucose, and 15 mM D-valine. D-Valine was included
to inhibit cellular arginase. [3H]Arginine (1.5 µCi/ml)
was added for an additional 20 min. After irradiation, culture medium
was aspirated, and culture dishes were snap-frozen on dry ice at the
indicated times. Cells were scraped into 25 mM Hepes (pH
5.5), 5 mM EDTA, 5 mM EGTA, 10 mM citrulline, sonicated, and cell lysates clarified by
micro-centrifugation for 10 min at 4 °C. The supernatant was mixed
with 0.5 ml of 50% Dowex AG 50-WX8 (Na+ form) equilibrated
with the above buffer to complex non-reacted arginine. After a short
micro-centrifugation, radioactivity of the eluate
([3H]citrulline) was determined by scintillation counting.
ROS/RNS Production--
Single cell analysis with a digitized
imaging system, radiation with a 90Sr source mounted on the
microscope, and dye loading conditions have been described (1, 15).
Dihydro-DCF, which becomes fluorescent upon oxidation, is a well
characterized dye for detecting ROS/RNS (15, 16, 33-35). The
spectroscopic properties of DCF (excitation at 490 nm, emission at 530 nm) do not permit ratiometric analysis and normalization for the
sampling volume. To achieve the latter, cells were simultaneously
loaded with fura-2, a Ca2+-sensitive dye, and fura-2
fluorescence was monitored at 530 nm with excitation at 360 nm, the
Ca2+-insensitive, isosbestic excitation wavelength of
fura-2 (15).
Immunoprecipitation/Western Blot Analyses--
Cells from
confluent 6-cm dishes were washed once with ice-cold phosphate-buffered
saline and scraped into 300 µl of lysis buffer (150 mM
NaCl, 1.0% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl (pH 8.0)). Lysates were incubated overnight with 1 µg of precipitating antibody followed by incubation for 1 h with protein G plus agarose beads (Calbiochem). Beads were washed
once in lysis buffer and twice in phosphate-buffered saline before
boiling for 5 min in SDS sample buffer. Proteins were analyzed by
standard Western blotting methods (7). Where quantitation was
indicated, the radiograms were scanned and densities determined with
Jandel SigmaScan software.
cGMP Measurements--
Cells in 35-mm dishes were transfected
with equal amounts (0.5 µg) of plasmids encoding the ERK1/2 Kinase Activity--
An immune complex kinase assay with
myelin basic protein as substrate was used to measure ERK1/2 kinase
activity (7). Activation of ERK1/2 was also assessed by Western blots
of cellular lysates with antibody specific for the phosphorylated,
activated forms of the kinases (anti-phospho-p44/42 E10 monoclonal
antibody, Cell Signaling Technology, Beverly, MA). Procedures followed
the manufacturer's protocol with cell lysates prepared from confluent
35-mm cell cultures.
Radiation Stimulates NOS-1 Activity in Epithelial
Cells--
CHO-K1 cells were irradiated at a clinically representative
dose of 2 Gy. NOS activities were assessed at the indicated
post-irradiation times by the amount of [3H]citrulline
formed and retained in both irradiated and sham-irradiated cells. In
the non-irradiated cells, the amount of cell associated [3H]citrulline was constant over the 30-min period
investigated. However, in cells exposed to radiation, NOS activity
(cell associated citrulline) was transiently enhanced with a maximal
fold activation of 1.58 ± 0.11 at 5 min post-irradiation (Fig.
1A). By 10 min after radiation
the fold activation had decreased to 1.33 ± 0.08 compared with
non-irradiated samples. By 30 min, NOS activity had returned to basal
levels.
Both pharmacological and genetic approaches were used to establish
further this assay of cellular NOS activity. L-NMMA is a
competitive inhibitor of all three NOS isoforms. As shown in Fig.
1A incubating cells for 60 min prior to radiation with 1 mM L-NMMA inhibited radiation-induced NOS
activity by more than 50%. Basal activity was equally inhibited by
this treatment. Another NOS inhibitor,
NG-nitro-L-arginine, also inhibited
basal and radiation-stimulated NOS activity (data not shown).
Previous studies (36) demonstrated that CHO-K1 cells express NOS-1.
Thus we tested whether we could manipulate basal and radiation-induced
NOS activities by overexpression of wild type NOS-1 or expression of a
dominant negative mutant. CHO-K1 cells were transfected with expression
plasmids encoding wild type rat brain NOS-1 (pnNOS) or a dominant
negative NOS-1 mutant (pHeme-RedF). The mutant protein encoded by
pHeme-RedF prevents dimerization of endogenous NOS-1 monomers and thus
inhibits NOS-1 activity (29). Relative expression levels of the wild
type and mutant proteins detected by Western blot are shown in the
inset to Fig. 1B. In the vector-control cells a
band that migrates with the same mobility as wild type rat brain NOS-1
is just detectable relative to cells transfected with either pnNOS or
pHeme-RedF. Immunoreactivity of this band is inhibited by the peptide
used to generate the NOS-1 antibody and is also reactive with other anti-NOS-1 antibodies but not antibodies directed against either NOS-2
or NOS-3 (data not shown).
Basal NOS activity of cells overexpressing wild type NOS-1 was not
significantly different from vector control cells. However, radiation-stimulated NOS activity was enhanced in the
NOS-1-overexpressing cells. In contrast, expression of the dominant
negative NOS-1 mutant protein reduced basal NOS activity by 35 ± 3% and almost completely inhibited radiation-stimulated activity (Fig.
1B). Similar results were obtained with another dominant
negative NOS-1 expression plasmid, pHeme (see Ref. 29 and data not shown).
To judge the relative quantitative significance of these
radiation-induced changes in cellular NOS-1 activity, we compared the
fold activation obtained with radiation with that observed after
increasing intracellular [Ca2+]. Cells were treated with
the Ca2+ ionophore, ionomycin, to maximally elevate
intracellular [Ca2+] or with ATP to activate purinergic
receptors and as a consequence stimulate a transient increase in
cytosolic
[Ca2+].2
Incubating cells with 10 µM ionomycin or 400 nM ATP for 5 min caused 3.3 ± 0.3- and 1.5 ± 0.2-fold, respectively, increases in NOS activity (n = 3 independent experiments). These increases in NOS activity are
comparable with those obtained with the radiation doses used here.
A previous study (36) reported that in CHO-K1 cells the protein-Tyr
phosphatase, SHP-2, was capable of dephosphorylating and as a
consequence activating NOS-1. We tested for a potential role for SHP-2
in radiation-mediated NOS-1 activation. NOS activity was measured by
the arginine-citrulline conversion assay with CHO-K1 cells transiently
transfected with plasmids encoding either wild type SHP-2 or the
dominant negative Cys459 Ionizing Radiation Enhances Cellular cGMP Formation--
An
important downstream target of NO is the heme-containing sGC.
Activation of sGC is therefore an indicator of NO formation. Because we
were unable to detect cGMP in CHO-K1 cells even with a highly sensitive
acetylation version of the ELISA kit for cGMP, cells were transfected
with expression plasmids encoding the Radiation Causes an Increase in RNS in CHO-K1 Cells--
Recent
investigations (15-17) using dihydro-DCF as an indicator dye have
argued that radiation stimulates ROS generation. Our studies
demonstrated that the underlying mechanism involved in part a
propagating reversible mitochondrial permeability transition. However,
dihydro-DCF is oxidized not only by OH· or
H2O2 in the presence of peroxidase but also by
ONOO Protein Tyr Nitration Increases After Radiation--
Protein
nitro-Tyr formation is considered to be a marker of ONOO
Control experiments (Fig. 5B) with inclusion of competing 10 mM 3-nitro-Tyr ethyl ester in with the immunoprecipitation
or Western blot antibodies established the specificity of the
antibodies for our cell system (37). Although 3-nitro-Tyr ethyl ester
was an effective inhibitor of the immunoprecipitation of Tyr-nitrated proteins, inhibition was incomplete as observed by the developers of
these antibodies (27). This contrasts with the complete inhibition in
the Western blot analysis and probably reflects the relative differences in the antibody affinities and antigen presentation as
discussed previously (27).
A previous study (37) demonstrated that Mn-SOD, a mitochondrial enzyme,
is Tyr-nitrated during ischemia reperfusion. Thus, we tested whether
Mn-SOD is nitrated following irradiation (Fig. 5C). At the
indicated times post-irradiation nitro-Tyr-labeled proteins were
immunoprecipitated, fractionated by gel electrophoresis, and resulting
blots probed with anti-Mn-SOD. A single band at 26 kDa was revealed,
the intensity of which increased and decreased as described with the
other proteins. To show that this nitration of Mn-SOD is the result of
radiation-induced NOS activity, similar experiments were performed with
cells expressing the dominant negative NOS-1 mutant, Heme-RedF. As
shown in Fig. 5D, the radiation-induced Tyr nitration of
Mn-SOD is decreased by greater than 50% in the Heme-RedF-expressing
cells compared with vector controls. Radiation-stimulated Tyr nitration
of Mn-SOD was also inhibited by the NOS inhibitor L-NMMA
(data not shown).
Radiation Stimulates ERK1/2 by a NO-dependent
Mechanism--
An early consequence of irradiation shown in several
cell types is the activation of ERK1/2 kinases (3, 5-7, 37). In cells
where it has been examined, the radiation-dependent
activation requires Ca2+ and an intact mitochondrial
electron transport chain (7, 15). As do other cells, CHO-K1 cells
exhibit a transient ERK1/2 activation centered at 3-5 min after
radiation and returning to basal levels by 10 min post-irradiation
(Fig. 6A). Results in this
figure also show that ERK1/2 stimulation is almost completely inhibited
when cells are treated with the NOS inhibitor L-NAME. In
contrast the ineffective stereoisomer D-NAME does not block
radiation-induced increases in ERK1/2 activity.
2-(4-Carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-oxy-3-oxide, a scavenger of NO (21), also prevents stimulation of ERK1/2 activity,
further establishing a role for NO in the radiation-stimulated ERK1/2
activity (Fig. 6B). In an effort to determine whether NO directly activates ERK1/2 or if ONOO
Results from these NOS inhibitor studies were confirmed in analyses
with cells expressing the dominant negative NOS-1 mutant or
overexpressing wild type NOS-1. Activation of ERK1/2 was determined by
Western blot analysis of lysates with monoclonal antibody specific for
the phospho-activated forms of ERK1/2 (Fig. 6C).
Overexpression of the wild type NOS-1 had no significant effect on
basal or radiation-induced ERK1/2 activation. Expression of the
dominant negative NOS-1 mutant, pHeme-RedF, was also without effect on
basal ERK1/2 activity. However, pHeme-RedF expression inhibited
radiation-induced activity by more than 50% in three independent
experiments. This substantial but incomplete inhibition compared with
that obtained with small molecule inhibitors probably reflects the less
than 100% transfection efficiency (82 ± 16%, n = 5 independent experiments with a green fluorescent protein expressing
plasmid). In addition, complete inhibition of NOS-1 activity may not be
achieved with cells expressing low levels of the dominant negative mutant.
Previous studies (15-17, 38) have demonstrated that radiation
stimulates metabolic ROS/RNS generation, a possible mechanism by which
cells sense and amplify cellular ionization events. Evidence presented
herein indicates that one component of this mechanism is a constitutive
NOS. Both basal and radiation-induced NOS activities of CHO-K1 cells
could be manipulated genetically or pharmacologically in a manner
consistent with radiation-stimulating NOS-1. The degree of activation
obtained with radiation compared favorably with that observed after
treating cells with a Ca2+ ionophore or a purinergic
receptor agonist. Downstream consequences of NO generation were
assayed. We determined that radiation activated NO-dependent sGC in a time frame consistent with the
measurements of NOS activity. In addition, radiation exposure also
enhanced protein Tyr nitration, a footprint of ONOO The mechanistic relationship between the radiation-induced
reversible mitochondrial permeability transition described
previously (15) and NOS-1 activation is unclear. One possibility lies
in localized Ca2+ transients that propagate the
permeability transition and can simultaneously activate the
Ca2+-dependent NOS-1. This mechanism is
supported by the recent finding that NOS-1 can associate with
mitochondria via its PDZ domain (39) putting NOS-1 at the origin of
mitochondria-released Ca2+. Possibly also involved in this
process is the ROS-induced ROS release that accompanies the
mitochondrial permeability transition and that may be necessary for its
propagation at least in cardiomyocytes (18). Previous studies (36) and
results presented here also demonstrate that the protein-Tyr
phosphatase SHP-2 modulates NOS-1 activity (Fig. 2). Overexpression of
wild type SHP-2 enhances whereas the dominant negative SHP-2 mutant
blocks radiation-stimulated NOS activity. This appears counterintuitive
because ROS and RNS inhibit Tyr phosphatases (e.g. Ref. 40),
and one would predict that ROS generated by radiation or metabolism
would inhibit SHP-2 and thus NOS-1. Ongoing studies are attempting to
resolve the role of SHP-2 in radiation-induced NOS-1 activation.
NO is the prototypic redox signaling molecule being more versatile than
either O RNS also induce a number of reversible protein thiol modifications
including S-nitrosylation and formation of sulfenic acids and both intramolecular (S-S) and mixed (S-SR, e.g.
glutathiolation) disulfides (41, 51). This of special importance to
radiation-induced activation of ERK1/2 which we have shown is
RNS-dependent (Fig. 6). Both positive and negative
regulatory components of ERK1/2 are potentially involved. The GTP
exchange activity of Ras is enhanced by nitrosylation of
Cys118 resulting in enhanced downstream signaling and
ERK1/2 activity (52, 53). On the other hand by dephosphorylating
ERK1/2, protein-Tyr phosphatases inhibit ERK1/2 activation. The
catalytic sites of protein-Tyr phosphatases are characterized by a Cys
within a consensus motif for S-nitrosylation (54). Oxidation
of this Cys inhibits phosphatase activity (40). Thus
S-nitrosylation of either Ras or a protein-Tyr phosphatase
could result in the enhanced ERK1/2 activity observed after radiation.
We are investigating both as mechanisms for the radiation-induced
modulation of Tyr kinase-dependent pathways including
ERK1/2.
Radiation-induced protein Tyr nitration of several proteins is also
observed, but its functional significance is unclear (Fig. 5). In the
case of Mn-SOD, high concentrations of ONOO The significance of Tyr nitration may lie more as being diagnostic for
ONOO The uniqueness of NO as a redox signaling molecule resides in part in
its relative stability and hydrophobic properties that permit its
diffusion across cell membranes over several cell diameter distances
(19). The present study demonstrating radiation-stimulated NO
generation suggests mechanisms by which an ionization event in one cell
can be sensed in neighboring cells. This may have significance not only
for radiotherapy but may represent one mechanism by which cells sense
and initiate trans-cellular signaling critical for tissues
in responding to localized oxidative events, e.g. metabolic
ROS generation, hypoxia, or low level environmental radiation.
*
This work was supported in part by United States Public
Health Service Grants CA65896, CA72955, and 5T32DK07150, developmental funds from the Massey Cancer Center, and a generous gift from Tanya Gordon.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Division of Bioengineering and Environmental
Health, Massachusetts Institute of Technology, Boston MA 02139.
**
To whom correspondence should be addressed. Tel.: 804-628-0857;
Fax: 804-828-6042; E-mail: rmikkels@vcu.edu.
Published, JBC Papers in Press, February 20, 2002, DOI 10.1074/jbc.M110309200
2
R. B. Mikkelsen, unpublished data.
The abbreviations used are:
ERK1/2, extracellular signal-regulated kinase 1/2;
DCF, dichlorofluorescein;
L-NAME, L-NG-nitroarginine methyl ester;
L-NMMA, L-NG-monomethylarginine;
MnTBAP, Mn (III)tetrakis (4-benzoic acid) porphyrin;
NOS, nitric-oxide
synthase;
ONOO
Activation of Constitutive Nitric-oxide Synthase Activity Is an
Early Signaling Event Induced by Ionizing Radiation*
§,
,
, and
**
Department of Radiation Oncology, Virginia
Commonwealth University, Richmond, Virginia 23298-0058 and the
¶ Division of Neonatology, Northwestern University,
Chicago, Illinois 60611-3008
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
citrulline conversion
assay. Irradiation stimulated a transient activation of NOS with
maximal activity at 5 min of post-irradiation. Western blot analysis
and genetic manipulation by overexpression of wild type or dominant negative NOS mutant identify the radiation-induced isoform as NOS-1.
Further evidence that NOS-1 is activated by radiation was the
demonstration of radiation-induced cGMP formation in cells transiently
transfected with the NO-dependent soluble guanylate cyclase. Protein Tyr nitration, a footprint of peroxynitrite formation, followed radiation exposure and was inhibited by expression of a
dominant negative NOS-1 mutant. Radiation-induced ERK1/2 kinase activity, a cytoprotective response to radiation, was also blocked by
inhibiting NOS activity. These experiments establish
NO-dependent signal transduction pathways as being
radioresponsive. Given the lipophilic and relatively stable properties
of NO, these results also suggest a possible mechanism by which
ionization events in one cell may activate signaling processes in
adjacent cells.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2000/Gy/cell) implicating sensitive detecting and amplifying mechanisms. Theoretical calculations rule out secondary products of the initial ionization events (e.g. H2O2 and
O


, mostly rearranges to form biologically inert
nitrite or reacts with GSH to form the NO donor GSNO (19, 23, 24).
However, when the [NO] approaches that of SOD, the resulting high
levels of ONOO
produce a number of cell-damaging effects
(19, 24). Thus, radiosensitization is observed with exogenous NO donors
or after cytokine stimulation of inducible NOS (NOS-2) expression
(e.g. Refs. 25 and 26). A cellular footprint of
ONOO
formation is the Tyr nitration of proteins (19,
27).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
- and
-subunits of sGC were provided by Dr. P. Yuen
(30). Dr. C. Susini provided the pSHP-1 wild type and pSHP-1c/s
plasmids. The latter Cys453
Ser mutant is
catalytically inactive and behaves as a dominant negative mutant (31).
The corresponding plasmids encoding Myc-tagged wild type and the
Cys459
Ser dominant negative SHP-2 mutant were obtained
from Dr. J. Pessin (32).
- and
-subunits of sGC. Forty eight h after transfection cells were
incubated for 30 min with 0.6 mM
3-isobutyl-1-methylxanthine to inhibit phosphodiesterases and
irradiated with 3 Gy. At the designated times, culture medium was
aspirated, and cells were lysed with 300 µl of 0.1 M HCl. cGMP levels in the lysates were measured with the non-acetylated version of a competitive ELISA assay kit (Biomol, Plymouth Meeting, PA).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Radiation activates NOS-1 in CHO-K1
cells. NOS activity was measured by the arginine
citrulline
conversion assay as described in the text. Radiation dose was 2 Gy, and
t = 0 was designated as the end of the radiation
period. A, cells were pre-equilibrated with 1 mM
L-NMMA 60 min prior to radiation.
, control;
, + L-NMMA. B, cells were transfected as described
under "Experimental Procedures." Cells were irradiated 48 h
post-transfection. The results represent the average ± S.E. of 3 independent experiments except for the identical controls. The controls
(19 independent experiments) are identical in both panels and are a
summation of controls from empty vector-transfected and non-transfected
cells. There was no statistical difference between the two.
,
Control;
, pHeme-RedF;
, pnNOS. Inset shows a Western
blot analysis of lysates from transfected cells (
20 µg for
pHeme-RedF and pnNOS-transfected cells and
40 µg for vector
control).
Ser SHP-2 mutant (32). Results
in Fig. 2A show that
expression of the Cys459
Ser SHP-2 mutant like the
dominant negative NOS-1 mutant almost completely suppresses
radiation-induced NOS activity. Overexpression of wild type SHP-2, on
the other hand, further enhanced the observed stimulation of NOS
activity by radiation (2.64 ± 0.66 versus 1.55 ± 0.05). This enhancement in the radiation response was similar to that
observed with cells overexpressing wild type NOS-1. The results from
experiments with wild type SHP-2 and Cys459
Ser SHP-2
mutant expression parallel those obtained in previous studies (36).
Similar experiments have also been performed with the wild type SHP-1
and Cys459
Ser dominant negative SHP-1 mutant, but the
expression of either protein had no effect on radiation-stimulated NOS
activity (Fig. 2B). We also tested whether NOS-1 in CHO-K1
cells was Tyr-phosphorylated as reported previously (36). Multiple
attempts with different antibodies directed against phospho-Tyr and
with or without immunoprecipitation of NOS-1 were unsuccessful in
demonstrating Tyr-phosphorylated NOS-1. Treatment of cells with 1 mM orthovanadate, a Tyr phosphatase inhibitor, for up to
1 h also did not alter the phosphorylation status of NOS-1. These
results suggest that some other protein whose activity is modulated by
SHP-2 is required for regulating NOS-1 activity after a radiation
exposure.

View larger version (16K):
[in a new window]
Fig. 2.
Radiation-induced NOS activity is modulated
by the Tyr phosphatase, SHP-2. A, cells were
transfected with plasmids encoding SHP-2 wild type (
) and dominant
negative Cys
Ser (C/S) SHP-2 mutant (
), and
48 h post-transfection, cells were irradiated (2 Gy) and NOS
activities measured with the arginine
citrulline conversion assay
and compared with vector controls (
). The results are the average of
triplicate samples ±S.E. of one experiment that is representative of
two independent experiments. B, identical experiments except
that cells were transfected with plasmids encoding SHP-1 wild type
(
) and dominant negative Cys
Ser (C/S) SHP-1
mutant (
) and compared with vector controls (
). The results are
the average of triplicate samples ± S.E. of one experiment
representative of two independent experiments.
- and
-subunits of sGC.
Forty eight h after transfection and 20 min prior to irradiation, cells
were incubated with the cAMP/cGMP phosphodiesterase inhibitor,
3-isobutyl-1-methylxanthine. Cells were irradiated at 3 Gy; cell
lysates were prepared at the indicated time points, and cGMP was
measured by a competitive ELISA kit. The data (Fig.
3) show that cGMP levels increase with
time following a radiation exposure. Control experiments with cells
expressing either the
- or
-subunit alone were negative
demonstrating that particulate guanylate cyclase was not activated by
radiation.

View larger version (15K):
[in a new window]
Fig. 3.
Radiation activates soluble guanylate
cyclase. CHO cells were transfected with both the
- and
-subunits of sGC. 48 h post-transfection cells were incubated
for 20 min with 0.6 mM 3-isobutyl-1-methylxanthine to
inhibit cyclic nucleotide phosphodiesterases and then irradiated at 3 Gy (
). Control non-irradiated cells were otherwise treated
identically (
). Cell lysates were prepared and cGMP measured as
described under "Experimental Procedures." The results are the
average of duplicate samples ± S.E. from one experiment and are
representative of two independent experiments. Cells transfected with
either vector alone or with an empty vector contained no measurable
cGMP.
(34, 35). ONOO
is a reaction product
of O
, we repeated these experiments with
and without different NOS inhibitors. As before, digitized fluorescence
microscopy was employed permitting single cell analysis. Typical
results (averaged over all the radio-responsive cells within the
microscopic field) are shown in Fig. 4.
The initial increase in DCF fluorescence representing oxidation of
dihydro-DCF is due to basal mitochondrial electron transport (15). The
radiation source is lowered to a fixed position just above the cells
initiating a radiation exposure of 1 Gy/10 s. This is accompanied by
enhanced rate of DCF fluorescence that is transient, lasting for 3-5
min before returning to the basal rate of increase (15).
H2O2 is added where indicated as a positive control. This same experiment was repeated with cells preincubated with
NOS inhibitors. The stereospecific inhibitor L-NAME
completely inhibited radiation-induced oxidation of
dihydro-DCF-oxidizing species, whereas the inactive stereoisomer,
D-NAME, was without effect. L-NMMA, another
competitive inhibitor of NOS, was also effective at inhibiting
radiation-induced dihydro-DCF oxidation (data not shown). These results
demonstrate that the radiation-induced oxidation of dihydro-DCF
requires NOS activity and that the likely oxidant measured is
ONOO
.

View larger version (16K):
[in a new window]
Fig. 4.
NOS inhibitors block radiation-induced
ROS/RNS generation detected by DCF fluorescence. Experimental
details are provided under "Experimental Procedures." A,
the results represent the average ±S.E. of the 6 cells responding (out
of 20 total in the field) to radiation (4 Gy). B, no cells
exhibited enhanced DCF fluorescence after the radiation exposure and
thus the results represent the average ± S.E. for all 20 cells
sampled in this experiment. B, cells were pre-equilibrated
with 1 mM L-NAME for 20 min prior to radiation
(4 Gy). H2O2 was added where indicated to 100 µM as a positive control. Results are from one experiment
representative of 2 independent experiments.
formation. Protein Tyr nitration was monitored by immunoprecipitation with mouse monoclonal anti-nitro-Tyr followed by immunoblotting with
rabbit polyclonal anti-nitro-Tyr. Fig.
5A shows a time course in
CHO-K1 cells for protein Tyr nitration after radiation. The protein
nitro-Tyr levels of several proteins are transiently increased with
maximal Tyr nitration at 5 min post-irradiation. Enhanced protein Tyr
nitration after radiation treatment was also observed in a number of
other cell lines including RAT-1 fibroblast, U87 glioma, HEK293, and
A431 squamous carcinoma cells.

View larger version (71K):
[in a new window]
Fig. 5.
Radiation stimulates protein Tyr
nitration. A, cell lysates from irradiated CHO-K1 cells
were incubated overnight with polyclonal anti-nitro-Tyr.
Immunoprecipitates were fractionated by SDS-gel electrophoresis and
Western blots probed with monoclonal anti-nitro-Tyr. Radiation dose was
2 Gy. B, cell lysates from 10-cm dishes were prepared either
before irradiation (t = 0 min) or 5 min
post-irradiation. Lysates were divided into three sets of aliquots as
follows: one set included 10 mM 3-nitro-L-Tyr
ethyl ester in the immunoprecipitation buffer (lanes 1 and
2), one set were controls (lanes 3 and
4), and the final set included 10 mM
3-nitro-L-Tyr ethyl ester in the Western blot buffer with
the primary antibody. C, anti-nitro-Tyr immunoprecipitates
were probed with anti-Mn-SOD. D, vector control cells or
cells transfected with the dominant negative NOS-1 mutant (pHeme-RedF)
were irradiated and cell lysates prepared either before irradiation or
5 min post-irradiation (2 Gy). Anti-nitro-Tyr immunoprecipitates were
obtained, electrophoretically fractionated, and Western blots probed
with anti-Mn-SOD. For all panels the results presented in each blot
have been reproduced in at least two independent experiments.
is involved in the
activation of ERK1/2, we incubated the cells with a SOD mimetic,
Mn-TBAP (21). Fig. 6B shows that Mn-TBAP abrogates ERK1/2
activation and implicates ONOO
in the activation of
ERK1/2.

View larger version (20K):
[in a new window]
Fig. 6.
ERK1/2 activation by radiation is
blocked by inhibiting NOS activity and NO scavengers. A
and B, ERK1/2 activity of CHO-K1 cells was measured by the
immune complex assay described under "Experimental Procedures"
before (t = 0) and after exposing cells to a radiation
dose of 2 Gy. A, cells were pre-incubated for 30 min with
either 1 mM L-NAME (
) or the inactive
stereoisomer D-NAME (
) prior to radiation.
,
untreated, irradiated control cells. B, cells were
pre-incubated for 1 h with 100 µM of either the NO
scavenger,
2-(4- carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-oxy-3-oxide
(carboxy-PTIO) (
), or the SOD mimetic, MnTBAP (
),
prior to radiation.
, untreated, irradiated control cells. The
results in both A and B represent the
average ± S.E. of three independent experiments. C,
ERK1/2 activity was assessed by Western blotting of cellular lysates
with monoclonal antibody directed against the phosphorylated activated
forms of ERK1/2. Cells were transfected as described under
"Experimental Procedures," and 48 h later, cells were
irradiated at 2 Gy. Cell lysates were prepared at the given time points
post-irradiation, and equal amounts of protein were loaded per lane.
These results are from one experiment representative of three
independent experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
formation. For one protein examined in detail, radiation-induced Tyr
nitration of Mn-SOD was inhibited by NOS inhibitors or by expression of
a dominant negative NOS-1 mutant. The combined results demonstrate that
ionizing radiation at doses of clinical relevance activate NOS-1.

catalyze
nitration on Tyr34 (9) resulting in inactivation. However,
results from an in-gel assay for Mn-SOD activity did not indicate an
effect of radiation on Mn-SOD activity in the time and dose ranges
studied here (data not shown). Tyr-nitrated proteins are preferentially
degraded by proteasomes, and this may explain why the
radiation-stimulated protein Tyr nitration is transient (10). There is
no definitive molecular evidence for mammalian denitrases (11, 12).
formation. Although high concentrations of
ONOO
can cause specific DNA base lesions,
ONOO
is highly unstable and mostly isomerizes to
relatively innocuous nitrates and nitrites (19). Wink et al.
(13) propose that this is a mechanism by which NO protects cells from
oxidative DNA damage caused by O
![]()
FOOTNOTES
Supported by United States Public Health Service Grants
HL60190 and HD398110.
![]()
ABBREVIATIONS
, peroxynitrite;
PKG, protein kinase G;
RNS, reactive nitrogen species;
ROS, reactive oxygen species;
sGC, soluble guanylate cyclase;
SOD, superoxide dismutase;
O
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Todd, D.,
and Mikkelsen, R. B.
(1994)
Cancer Res.
54,
5224-5230 2.
Schmidt-Ullrich, R.,
Dent, P.,
Grant, S.,
Mikkelsen, R. B.,
and Valerie, K.
(2000)
Radiat. Res.
153,
245-257[Medline]
[Order article via Infotrieve] 3.
Stephenson, M. A.,
Pollock, S.,
Coleman, N. C.,
and Calderwood, S.
(1994)
Cancer Res.
54,
12-15 4.
Kharbanda, S.,
Yuan, Z.-M.,
Rubin, E.,
Weichselbaum, R.,
and Kufe, D.
(1994)
J. Biol. Chem.
269,
20739-20743 5.
Kharbanda, S.,
Saleem, A.,
Shafman, T.,
Emoto, Y.,
Weichselbaum, R.,
and Kufe, D.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5416-5420 6.
Kasid, U.,
Suy, S.,
Dent, P.,
Ray, S.,
Whiteside, T. L.,
and Sturgill, T. W.
(1996)
Nature
382,
813-816[CrossRef][Medline]
[Order article via Infotrieve] 7.
Kavanagh, B. D.,
Dent, P.,
Schmidt-Ullrich, R. K.,
Chen, P.,
and Mikkelsen, R. B.
(1998)
Radiat. Res.
149,
579-587[Medline]
[Order article via Infotrieve] 8.
Haimovitz-Friedman, A.,
Kan, C.-C.,
Ehleiter, D.,
Persaud, R.,
McLaughlin, M.,
Fuks, Z.,
and Kolesnick, R.
(1994)
J. Exp. Med.
180,
525-535 9.
Yamakura, F.,
Taka, H.,
Fujimura, T.,
and Murayama, K.
(1998)
J. Biol. Chem.
273,
14085-14089 10.
Gow, A. J.,
Duran, D.,
Malcolm, S.,
and Ischiropoulos, H.
(1996)
FEBS Lett.
385,
63-66[CrossRef][Medline]
[Order article via Infotrieve] 11.
Kamisaki, Y.,
Wada, K.,
Bian, K.,
Balbanli, B.,
Davis, K.,
Martin, E.,
Behbod, F.,
Lee, Y.,
and Murad, F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11584-11589 12.
Kuo, W.-N.,
Kanadia, R.,
Shanbhag, V. P.,
and Toro, R.
(1999)
Mol. Cell. Biochem.
201,
11-16[CrossRef][Medline]
[Order article via Infotrieve] 13.
Wink, D. A.,
Hanbauer, I.,
Krishna, M. C.,
DeGraff, M. C.,
Gamson, W.,
and Mitchell, J. B.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9813-9817 14.
Ward, J.
(1994)
Radiat. Res.
138,
S85-S88[Medline]
[Order article via Infotrieve] 15.
Leach, J.,
Van Tuyle, G.,
Lin, P.-S.,
Schmidt-Ullrich, R.,
and Mikkelsen, R. B.
(2001)
Cancer Res.
61,
3894-3901 16.
Narayanan, P.,
Goodwin, E.,
and Lehnert, B.
(1997)
Cancer Res.
57,
3963-3971 17.
Clutton, S.,
Townsend, K.,
Walker, C.,
Ansell, J.,
and Wright, E.
(1996)
Carcinogenesis
17,
1633-1639 18.
Zorov, D. B.,
Filburn, C. R.,
Klotz, L. O.,
Zweier, J. L.,
and Sollott, S. J.
(2000)
J. Exp. Med.
192,
1001-1014 19.
Beckman, J. S.,
and Koppenol, W. H.
(1996)
Am. J. Physiol.
271,
C1424-C1437 20.
Goda, N.,
Suematsu, M.,
Mukai, M.,
Kiyokawa, K.,
Natori, M.,
Nozawa, S.,
and Ishimura, Y.
(1997)
Am. J. Physiol.
271,
H1893-H1899 21.
Janssen, M. Y. W.,
Soultanakis, R.,
Steece, K.,
Heerdt, E.,
Singh, R. J.,
Joseph, J.,
and Kalyanaraman, B.
(1998)
Am. J. Physiol.
275,
L1100-L1109 22.
Niu, X. F.,
Ibbotson, G.,
and Kubes, P.
(1996)
Circ. Res.
79,
992-999 23.
Balazy, M.,
Kaminski, P. W.,
Mao, K.,
Tan, J.,
and Wolin, M. S.
(1998)
J. Biol. Chem.
273,
32009-32015 24.
Ducrocq, C.,
Blanchard, B.,
Pignatelli, B.,
and Ohshima, H.
(1999)
Cell. Mol. Life Sci.
55,
1068-1077[CrossRef][Medline]
[Order article via Infotrieve] 25.
Ibuki, Y.,
and Goto, A.
(1997)
Free Radic. Biol. Med.
22,
1029-1035[CrossRef][Medline]
[Order article via Infotrieve] 26.
Janssens, M. Y.,
Van den Berge, D. L.,
Verovski, V. N.,
Monsaert, C.,
and Storme, G. A.
(1998)
Cancer Res.
58,
5646-5648 27.
MacMillan-Crow, L. A.,
Crow, J. P.,
Kerby, J. D.,
Beckman, J. S.,
and Thompson, J. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11853-11858 28.
Stuehr, D.
(1999)
Biochim. Biophys. Acta
1411,
217-230[Medline]
[Order article via Infotrieve] 29.
Phung, Y. T.,
and Black, S. M.
(1999)
IUBMB Life
48,
333-338[Medline]
[Order article via Infotrieve] 30.
Yuen, P. S.,
Doolittle, L. K.,
and Garbers, D. L.
(1994)
J. Biol. Chem.
269,
791-793 31.
Lopez, F.,
Esteve, J. P.,
Buscail, L.,
Delesque, N.,
Saint-Laurent, N.,
Theveniau, M.,
Nahmias, C.,
Vaysse, N.,
and Susini, C.
(1997)
J. Biol. Chem.
272,
24448-24454 32.
Yamauchi, K.,
Milarski, K. L.,
Saltiel, A. R.,
and Pessin, J. E.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
664-668 33.
Miranda, S.,
Foncea, R.,
Guerrero, J.,
and Leighton, F.
(1999)
Biochem. Biophys. Res. Commun.
258,
44-49[CrossRef][Medline]
[Order article via Infotrieve] 34.
Crow, J. P.
(1997)
Nitric Oxide
1,
145-157[CrossRef][Medline]
[Order article via Infotrieve] 35.
Possel, H.,
Noack, H.,
Augustin, W.,
Keilhoff, G.,
and Wolf, G.
(1997)
FEBS Lett.
416,
175-178[CrossRef][Medline]
[Order article via Infotrieve] 36.
Cordelier, P.,
Esteve, J. P.,
Rivard, N.,
Marletta, M.,
Vaysse, N.,
Susini, C.,
and Buscail, L.
(1999)
FASEB J.
13,
2037-2050 37.
Bonner, J. A.,
Vroman, B. T.,
Christianson, T. J. H.,
and Karnitz, L. M.
(1998)
Int. J. Radiat. Oncol. Biol. Phys.
42,
921-925[CrossRef][Medline]
[Order article via Infotrieve] 38.
Morales, A.,
Miranda, M.,
Sanchez-Reyes, A.,
Biete, A.,
and Fernandez-Checa, J.
(1998)
Int. J. Radiat. Oncol. Biol. Phys.
42,
191-204[CrossRef][Medline]
[Order article via Infotrieve] 39.
Kanai, A. J.,
Pearce, L. L.,
Clemens, P. R.,
Birder, L. A.,
VanBibber, M. M.,
Choi, S. Y.,
de Groat, W. C.,
and Peterson, J.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
14126-14131 40.
Barrett, W. C.,
DeGnore, J. P.,
Keng, Y. F.,
Zhang, Z.-Y.,
Yim, Y. B.,
and Chock, P. B.
(1999)
J. Biol. Chem.
274,
34543-34546 41.
Stamler, J. S.,
Lipton, S. A.,
and Sucher, N. J.
(1997)
Neuron
18,
691-696[CrossRef][Medline]
[Order article via Infotrieve] 42.
Marshall, H. E.,
Merchant, K.,
and Stamler, J. S.
(2000)
FASEB J.
14,
1889-1900 43.
Zhou, X.-B.,
Ruth, P.,
Schlossmann, J.,
Hofmann, F.,
and Korth, M.
(1996)
J. Biol. Chem.
271,
19760-19767 44.
Becker, E. M.,
Wunder, F.,
Kast, R.,
Robyr, C.,
Hoenicka, M.,
Gerzer, R.,
Schroder, H.,
and Stasch, J. P.
(1999)
Nitric Oxide
3,
55-66[CrossRef][Medline]
[Order article via Infotrieve] 45.
Komalavilas, P.,
Shah, P. K., Jo, H.,
and Lincoln, T. M.
(1999)
J. Biol. Chem.
274,
34301-34309 46.
Gudi, T.,
Huvar, I.,
Meinecke, M.,
Lohmann, S. M.,
Boss, G. R.,
and Pilz, R. B.
(1996)
J. Biol. Chem.
271,
4597-4600 47.
Chiche, J.-D.,
Schlutsmeyer, S. M.,
Block, D. B.,
de la Monte, S. M.,
Roberts, J. D.,
Filippov, G.,
Janssens, S. P.,
Rosenzweig, A.,
and Bloch, K. D.
(1998)
J. Biol. Chem.
273,
34263-34271 48.
Browning, D.,
McShane, M. P.,
Marty, C.,
and Ye, R. D.
(2000)
J. Biol. Chem.
275,
2811-2816 49.
Suhasini, M., Li, H.,
Lohmann, S. M.,
Boss, G. R.,
and Pilz, R. B.
(1998)
Mol. Cell. Biol.
18,
6983-6994 50.
Gu, M.,
Lynch, J.,
and Brecker, P.
(2000)
J. Biol. Chem.
275,
11389-11396 51.
Collins, S. P.,
and Uhler, M.
(1999)
J. Biol. Chem.
274,
8391-8404 52.
Deora, A. A.,
Hajjar, D.,
and Lander, H.
(2000)
Biochemistry
39,
9901-9908[CrossRef][Medline]
[Order article via Infotrieve] 53.
Lander, H. M.,
Ogiste, J. S.,
Teng, K. K.,
and Novogrodsky, A.
(1995)
J. Biol. Chem.
270,
21195-21198 54.
Tonks, N. K.,
and Neel, B. G.
(1996)
Cell
87,
365-368[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. S. Isenberg, J. B. Maxhimer, F. Hyodo, M. L. Pendrak, L. A. Ridnour, W. G. DeGraff, M. Tsokos, D. A. Wink, and D. D. Roberts Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation Injury Am. J. Pathol., October 1, 2008; 173(4): 1100 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Lee, S. An, H. Lee, S.-H. Woo, H.-O. Jin, S.-K. Seo, T.-B. Choe, D.-H. Yoo, S.-J. Lee, Y.-J. Hong, et al. Activation of Epidermal Growth Factor Receptor and Its Downstream Signaling Pathway by Nitric Oxide in Response to Ionizing Radiation Mol. Cancer Res., June 1, 2008; 6(6): 996 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Han, L Wu, B Hu, L Zhang, S Chen, L Bao, Y Zhao, A Xu, and Z Yu The early and initiation processes of radiation-induced bystander effects involved in the induction of DNA double strand breaks in non-irradiated cultures Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S7 - S12. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Zhao, D I Diz, and M E Robbins Oxidative damage pathways in relation to normal tissue injury Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S23 - S31. [Abstract] [Full Text] [PDF] |
||||
![]() |
|